Fifth Alcor Conference on Extreme Life Extension (2002)

Fifth Alcor
Conference
on Extreme Life Extension













Alcor’s 30th anniversary!

November 16 to 17, 2002
at the Newport
Beach Marriott near Los Angeles, California

An Introductory Tutorial will be held on November 15




This conference is over this web site provides
archival information



Alcor: providing human cryopreservation services
since 1972









Conference Chairs:

Ralph
C. Merkle

Kat

Cotter, D.C.


Publicity about
the conference:

Orange County Register, November 17th
2002: There’s
no gray area in anti-aging ranks

"This weekend in Newport Beach, at
the 5th [Alcor] annual Extreme Life Extension Conference, a
bunch of A-list scientists are gathered to discuss a B-movie
idea: living long enough to live forever."

Wired News, November 18th
2002: Ray
Kurzweil’s Plan: Never Die

"Ray Kurzweil, celebrated
author, inventor and geek hero, plans to live forever."

Wired News, November 20th
2002: A
Few Ways to Win Mortality War

"Discussions among leading
researchers in nanotechnology, cloning and artificial intelligence
focused on much more than cryonics, the process of freezing the
body in liquid nitrogen after death to be later reanimated. Cryonics
is basically a backup plan if technology doesn’t obliterate mortality
first."

Wired News, November 20th 2002:
Who
Wants to Live Forever?

"Gregory Benford, of the
University of California at Irvine, believes the public should
know that ‘cryonicists aren’t crazy, they’re just really great,
sexy optimists.’"

KurzweilAI.net, November 22nd
2002:The
Alcor Conference on Extreme Life Extension

"Bringing together longevity
experts, biotechnology pioneers, and futurists, the conference
explored how the emerging technologies of biotechnology, nanotechnology,
and cryonics will enable humans to halt and ultimately reverse
aging and disease and live indefinitely."



   

General

Speakers

Topics  

Tutorial  

 

Sponsors

Speaker
Bios

 
 

Registration

Abstracts

 
 

The First Immortal

Program/Schedule

 
   

Media Inquiries

 



General



The Fifth Alcor Conference on Extreme
Life Extension
will be held at the Newport
Beach Marriott Hotel, 900 Newport Center Drive, Newport Beach, California
92660. The Conference will begin with a reception the evening of Friday, November
15; and end Sunday, November 17, 2002. An intensive Tutorial on Fundamental
Issues in Extreme Life Extension
will be held on November 15.


John Wayne Airport
(SNA) in Orange County California is 15 minutes from the Conference hotel.
The hotel runs a complementary shuttle every hour at the bottom of the hour.
Los Angeles International
Airport (LAX) is 50 minutes.


We have arranged with Southwest Airlines for a 10% discount
off most fares for air travel to and from the conference. Call Southwest Airlines
Group and Meetings Reservations at 1-800-433-5368 and reference I.D. Code
J7022. Make reservations five or more days before you want to travel to take
advantage of this discount. Airports covered are SNA, BUR and LAX. Travel
dates must be between November 10th and 25th.


Conference URL: http://www.alcor.org/conferences/2002/



Topics Covered



We live longer and healthier lives today than in centuries
past because of remarkable advances in medical technology. We’ve already sequenced
the human genome, cloned mammals, and replaced the human heart with an artificial
pump. Soon we will understand the basic mechanisms of life. Not only is our
understanding deepening, we are also gaining the ability to modify, control
and repair the fundamental molecular and cellular structures from which we
are made. Age and infirmity will become as rare as bubonic plague and smallpox.
Youthful vigor and long lasting good health will be the norm. How rapidly
these advances take place and the extent to which we as individuals benefit
from them depends very much on what we do. The Fifth Alcor Conference on Extreme
Life Extension is a meeting of scientists and individuals who are working
toward the expansion of human health and longevity. This conference will cover
topics relevant to these pursuits including:











  • cryobiology
  • tissue engineering
  • cryonics
  • nanomedicine
  • genetic engineering



  • therapeutic cloning
  • vitrification

  • cryonics estate planning
  • anti-aging medicine
  • medical nanodevices



Speakers

Keynote:
Michael
D. West

President & CEO of Advanced
Cell Technology

Human Therapeutic Cloning:
Opportunities and Challenges


Ray
Kurzweil

recipient of the 1999
National Medal of Technology
, Kurzweil
Technologies

The
Singularity is Near

A
Bridge to a Bridge to a Bridge


Gregory
Benford

Professor of Physics,
University of California, Irvine. In a two page profile Science
Magazine
called him "…a mild-mannered professor who doubles
as the working physicist’s science fiction writer."

Cryonics
in the Long View


K.
Eric Drexler

Chairman, Foresight Institute

Time said “…a few centuries hence, the name Eric Drexler
just might appear alongside those of Einstein and Freud”
Newsweek called him one of “100 people to watch
in the next millennium.”

Hear the world’s foremost expert on nanotechnology explain
the amazing potential of this coming revolution in technology. Drexler
is the author of Engines
of Creation
and Nanosystems:
Molecular Machinery, Manufacturing, and Computation
; the founding
books in the field.

Nanotechnology:
The Upside


Gregory
Benford
, Professor of Physics,
University of California, Irvine
Cryonics
in the Long View
Kat
Cotter
, D.C., Vice President, Maximum
Life Foundation
Extending
Your Healthspan Now
K.
Eric Drexler, Chairman, Foresight
Institute
Nanotechnology: The Upside
Aubrey
de Grey
, Department of Genetics
University of Cambridge
Engineering
negligible senescence: rational design of feasible, comprehensive rejuvenation
biotechnology
Gregory
Fahy
, Chief Scientific Officer of 21st
Century Medicine
Organ
Cryopreservation Research at 21st Century Medicine
Robert
A. Freitas, Jr.
, author, Nanomedicine;
Research Scientist, Zyvex
Nanomedicine:
Impact on Global Mortality
Steven
B. Harris
, MD, Director of Research, Critical
Care Research
Improvements
in Rapid Cooling to Save the Brain
Rudi
Hoffman
, Certified Financial Planner
The
Affordable Immortal: How YOU can fund the new science of Biostasis
David
A. Kekich
, founder, Maximum Life Foundation
New
Venture Capital Solution For Life Extension Projects
Kathy Kriese Panel: Women in Cryonics
Ray
Kurzweil
, recipient of the 1999
National Medal of Technology
, Kurzweil
Technologies
The
Singularity Is Near and A Bridge to a Bridge to a Bridge
Jerry
Lemler
, President and CEO, Alcor
Alcor
at 30: Where Do We Go From Here?
Ralph
C. Merkle
, Alcor Director; Vice President, Technology Assessment, Foresight
Institute
Conference Introduction
Max
More
, President, Extropy Institute
Mind
the Gap: Strategic Scenario Analysis for Your Second Life
Natasha
Vita-More
, media artist, lecturer and writer
Panel: Women in Cryonics
Christine
Peterson
, President, Foresight Institute
Judging
Life Extension Technologies
Michael
Rose
, Professor, Evolutionary Biology
of Aging, Evolutionary Genetics; University of California at Irvine
Prospects
for Biological Immortality
Stephen
Spindler
, Professor of Biochemistry, University of California, Riverside
Chipping
Away at the Mysteries of Aging: what you don’t eat can’t hurt you.
Michael
D. West
, President & CEO of Advanced
Cell Technology
Human Therapeutic Cloning: Opportunities
and Challenges
Brian
Wowk
, Research Scientist, 21st Century
Medicine
Issues
and Technologies for Long-Term Tissue Storage

Tutorial on Fundamental Issues in Extreme Life Extension


Speakers

Subjects

Gregory
Fahy
and Brian
Wowk
Extreme
Life Prolongation at Cryogenic Temperatures
Ralph
C. Merkle
Nanotechnology:
how it will transform medicine and enable repair of cryopreserved tissue
Aubrey
de Grey
Cancer,
telomerase and aging
Jerry
Lemler
and Alcor Staff
The
New Alcor Human Cryopreservation Protocols


Sponsors

Alcor Life Extension Foundation,
Foresight Institute, and Future Electronics.

What is Cryonics?

A Free Introduction to Life Extension Sponsored by the
Alcor Life Extension Foundation

Thursday November 14th from 7:00 pm to 8:30 pm. Ralph
Merkle
, Vice President of Technology Assessment, Foresight Institute and
Jerry Lemler,
President and CEO of Alcor, will introduce you to cryonics. Mary Naples, CLU,
ChFC, will discuss life insurance for cryonics. This will be followed by a
panel with audience Q&A, and the evening will end with informal discussion
and socializing. Call 800-482-6791 to RSVP.

Introduce your friends and relatives to cryonics

Give them a copy of the novel The
First Immortal
.

Media inquiries

For all media inquiries, materials and press credentials,
send e-mail to:

1231

Program

5th Alcor Conference on Extreme
Life Extension
Preliminary Conference Program

 

Final Program

 
 

 

 

Thursday, November 14th FREE
session

6:30 PM Staff meeting
7:00-8:30 PM What is Cryonics?
A Free Introduction to Life Extension Sponsored by the Alcor Life Extension
Foundation
Lobby Level of the Marriott.
Call 800-482-6791 to RSVP

Will
Cryonics Work?

Ralph C. Merkle, Vice President, Technology
Assessment, Foresight Institute

You
Only Go Around Twice

Jerry Lemler, President and CEO, Alcor
    Life
Insurance for Cryonics

Mary Naples, CLU, ChFC
    Panel
and audience Q&A
Socializing

Friday, November 15th

7:50 AM Staff meeting
8:00 AM Registration open till 10:00 AM
8:00 AM Continental Breakfast
8:50
AM
Tutorial
8:50 AM Tutorial Introduction
Ralph C. Merkle, Foresight Institute
9:00 AM Nanotechnology: how it
will transform medicine and enable repair of cryopreserved tissue

Ralph C. Merkle, Foresight Institute
10:30 AM Break
11:00 AM Extreme Life Prolongation
at Cryogenic Temperatures

Gregory Fahy and Brian Wowk, 21st Century Medicine
12:30 PM Lunch
1:30 PM Cancer, telomerase and
aging

Aubrey de Grey, University of Cambridge
3:00 PM Break
3:30 PM The New Alcor Cryonic
Suspension Protocols

Jerry Lemler and Alcor Staff, Alcor Life Extension Foundation
5:00 PM Closing Remarks, Ralph Merkle
6:00 PM Conference Registration open till
10:00 pm
7:00
PM
Conference Reception
























































































































Saturday, November 16th


7:15 AM Staff meeting
7:30 AM Conference Registration
open till 10:00 AM
8:00 AM Continental Breakfast
8:50 AM Introduction and Welcome
Ralph C. Merkle, Conference Chair,
9:00 AM

Alcor at 30: Where Do We Go from Here?
Jerry Lemler

9:30 AM Nanomedicine: impact on
global mortality

Robert Freitas
10:10 AM Break
10:40 AM The Singularity is Near

Ray Kurzweil
11:20 AM Engineering Negligible Senescence
Aubrey de Grey
12:00 Noon Lunch
1:30 PM Cryonics in the Long View
Gregory Benford
2:10 PM Judging Life Extension Technologies
Christine Peterson
2:50 PM Mind the Gap: Strategic
Scenario Analysis for Your Second Life

Max More
3:30 PM Break
4:00 PM Extending Your Healthspan
Now

Kat Cotter
4:40 PM Improvements in Rapid Cooling
to Save the Brain

Steve Harris
5:20 PM Closing remarks
5:30 PM End of Session
5:30 PM Alcor membership application
and discussions (informal)
8:00 PM Speaker/VIP reception
(invitation only)



Sunday, November 17th


8:00 AM Staff meeting
8:00 AM Continental Breakfast
8:10 AM The Affordable Immortal:
How YOU can fund the new science of Biostasis

Rudi Hoffman
8:50 AM Opening Remarks
Kat Cotter
9:00 AM Keynote: Human Therapeutic
Cloning: Opportunities and Challenges

Michael D. West, President and CEO, Advanced Cell Technology
10:00 AM Organ Cryopreservation
Research at 21st Century Medicine

Gregory Fahy
10:40 AM Break
11:10 AM Issues and Technologies
for Long-Term Tissue Storage

Brian Wowk
11:50 AM Prospects for Biological
Immortality

Michael Rose
12:30 AM Lunch and Leonard N. Zubkoff Memorial
Award
2:00 PM Chipping Away at the Mysteries
of Aging: what you don’t eat can’t hurt you.

Stephen Spindler
2:40 PM A Bridge to a Bridge to
a Bridge

Ray Kurzweil
3:20 PM Break
3:50 PM

Women in Cryonics
Moderator: Kat Cotter
Panelists: Christine Peterson, Natasha Vita-More, Kathy Kriese, Gilda
Cabral

4:30 PM

Nanotechnology: the upside
K. Eric Drexler

5:10 PM

New Venture Capital Solution For Life Extension
Projects

Dave Kekich

5:40 PM Closing remarks




Speaker Abstracts

Fifth
Alcor Conference
on Extreme Life Extension


Alcor: providing human cryopreservation services since 1972

Speaker Abstracts


Gregory Benford

Cryonics in the Long View

If we make it at all, we shall emerge into a society quite different from ours.
How can we envision that? And how can it help us to do so?


Kat Cotter, D.C.

Extending Your Healthspan Now

What
can be done right now to help you take control of your own aging process? Hear
from the director of The Longevity Bootcamp – the first conference on aging
designed for the general public. At the last Bootcamp (held this year) fifteen
world-renowned experts in various fields of anti-aging, longevity and life
extension research shared the knowledge they’ve spent their lifetimes gaining,
knowledge about the latest information on how to potentially slow aging. Dr.
Cotter brings you the best of the best from this conferencecutting-edge
information and the best advice distilled from two days of presentations.
Topics will include current and potential future breakthroughs in nutrition,
diet, life-extending supplementation, exercise, HGH and other hormones, stress
reduction, diagnostic screenings and preventive tests.


Aubrey de Grey

Engineering negligible senescence: rational design of feasible,
comprehensive rejuvenation biotechnology

We
now have a detailed understanding of where and how our natural maintenance and
repair systems fail to work indefinitely, and also a large arsenal of tools
that can potentially be used to improve them. Hence, we can at last approach
the goal of extreme life extension with a hard-headed, engineering frame of
mind. I have recently joined with several noted biogerontologists to explore
how extreme life extension ("negligible senescence") can be
engineered in the foreseeable future. In this talk I will describe the
components of our proposed strategy, with emphasis on the two areas in which I
am most heavily involved (mitochondrial mutations and lysosomal aggregates).


Greg Fahy

Organ Cryopreservation Research at 21st Century Medicine

21st
Century Medicine is the only organization actively pursuing the
cryopreservation of whole organs. Current efforts are based on a number of
major advances in fundamental cryobiology, including toxicity control, ice
control, chilling injury control, and carrier solution development, plus
significant advances in surgical techniques and perfusion technology. The
result has been the ability to perfuse whole kidneys with cryoprotectants at
concentrations that formerly were uniformly fatal, but which currently produce
little or even no injury, despite absence of formerly-mandatory supportive
drugs. 21st has also begun a similar, full-time program devoted to brain
cryopreservation, which will be described.


Robert A. Freitas, Jr.

Nanomedicine: Impact on Global Mortality

Each
year, medically preventable natural deaths impose terrible costs on humanity,
including the destruction of vast quantities of human knowledge and human
capital. Future medical technologies, especially nanomedicine, may permit us
first to arrest, and later to reverse, the biological effects of aging and most
of the current causes of natural death. Respirocytes (artificial red cells) and
microbivores (artificial white cells) provide examples of the new capabilities
that medical nanorobotics may offer in the decades to come.


Steven B. Harris

Improvements in Rapid Cooling to Save the Brain

The
protective effect of pre-existing hypothermia against ischemic injury has been
long known. What is relatively recent, however, is the observation that
hypothermia applied after the ischemic insult has already happened can still
provide nearly miraculous benefits in assisting brain recovery. For example,
dogs subjected to more than 5 min of normal body temperature cardiac arrest,
like humans, experience severe brain damage and death when given conventional
treatments, but if they are put into mild hypothermia after even 17 minutes of
normothermic cardiac arrest, they can be resuscitated without detectable brain
damage.


Rudi Hoffman

The Affordable Immortal: How YOU can fund the new science of Biostasis

Cryonic
suspension immediatly upon legal death may be a way to preserve individual
lives. It is now possible to use the leverage of life insurance to pay for the
costs of suspension. It is also possible to create an instant estate that can
go to your family and can also be structured to fund a trust which can be
available for you upon "reanimation." Various kinds of insurance will
be discussed, and trade-offs and costs of term insurance, Universal Life, Whole
Life, and Variable Life will become clear. You won’t want to miss this
explanation of "Why Insurance Is Not Boring Anymore!"


David A. Kekich

New Venture Capital Solution For Life Extension Projects

Traditional
venture capital can help extend our lives by about 15 years. A longer term
funding approach might buy us 1500. Even though more venture capital now goes
to biotechs than ever before, only about 10% goes to start-ups. And hardly any
of it is invested in life extension research. DEALS, TransVio Technology
Ventures’ new patented venture capital tool could change that. Funding can finally
start now for critical longer-term projects. DEALS eliminates almost all the
investor’s risk, and actually pays them to participate while providing
entrepreneurs with all the funding they need through the life of their
projects.


Ray Kurzweil

The Singularity is Near

Communication
bandwidths, the shrinking size of technology, our knowledge of the human brain,
and human knowledge in general are all accelerating. Three-dimensional
molecular computing will provide the hardware for human-level
"strong" AI well before 2030. The more important software insights
will be gained in part from the reverse-engineering of the human brain, a
process well under way. Once nonbiological intelligence matches the range and
subtlety of human intelligence, it will necessarily soar past it because of the
continuing acceleration of information-based technologies, as well as the
ability of machines to instantly share their knowledge. Intelligent nanorobots
will be deeply integrated in the environment, our bodies and our brains,
providing vastly extended longevity, full-immersion virtual reality
incorporating all of the senses, experience "beaming," and enhanced
human intelligence. The implication will be an intimate merger between the technology-creating
species and the evolutionary process it spawned.


Ray Kurzweil

A Bridge to a Bridge to a Bridge

Ray
Kurzweil describes how you can live to see (and enjoy!) the
"Singularity," a profound transformation in what it means to be
human, which will arrive by mid century. The leading causes of death (heart
disease, cancer, stroke, diabetes, kidney disease, liver disease) do not appear
out of the blue. They are the end result of processes that are decades in the
making. You can understand where you are personally in the progression of these
processes and end (and reverse) the lethal march towards these diseases. Ray
Kurzweil presents a program he devised in collaboration with longevity expert
Terry Grossman, M.D. that describes how longstanding imbalances in our
metabolic processes can be corrected before you "fall off the cliff."
This information is not "plug and play," but the knowledge is
available and can be applied through a comprehensive and concerted effort. Ray
and Terry’s Program for a Long and Healthy Life is a bridge to the full
blossoming of the biotechnology revolution, which in turn will be a bridge to
the nanotechnology–AI (artificial intelligence) revolution. The latter
revolution will radically redefine our concept of human mortality.


Jerry Lemler

Alcor at 30: Where Do We Go From Here?

Being
proud of three decades of stability is one thing–being complacent is another.
This presentation will trace the foundation’s antecedent roots, and offer the
viewer/listener a glimpse of what’s in store around the bend ahead.


Max More

Mind the Gap: Strategic Scenario Analysis for Your Second Life

Max
More crossed the Atlantic abyss, moving from England to Southern California.
Others have made much more dramatic cultural relocations, such as Aboriginal
Australians who have moved to New York City. Those of us who require biostasis
to make it into the further future, will make a dramatic jump. The longer we
are in suspension the more disruptive the change and the harder the adjustment.
To make this jump and maximize our chances of psychologically successful
revival, we have the responsibility to prepare ahead of time. Part of this
means financial planning and "LifePact" type arrangements. This talk
will focus on strategic approaches to post-revival flourishing. This includes
using scenario thinking, using cognitive psychology to overcome limited thinking,
and identifying and developing skills for innovation and the capacity to adapt
to novel environments & circumstances.


Christine Peterson

Judging Life Extension Technologies

Because
life extension technologies are drawn from a wide variety of technical fields,
it’s difficult for individuals to judge which ones are worth pursuing. We’ll
look at the most challenging ones and ask how a layperson can go about making
these confusing choices: which supplements to take, which prescriptions to ask
for, and whether to arrange for biostasis (cryonics). The goal here is not to
give the answers, which vary for each person, but to sketch how we can each
approach the challenge of making these tough decisions, given that mainstream
sources of information often lag far behind the latest research.


Michael Rose
Prospects for Biological Immortality

Since
1992, the study of biological immortality has been transformed from a dubious
curiosity to an active focus of theoretical and experimental research. If
biological immortality is defined as the absence of a sustained increase in
rates of mortality as a function of age, then it is now an established scientific
fact. Some organisms attain biological immortality early in life. In most
organisms, biological immortality arises very late in life, after a prolonged
period of rising mortality rates, or aging. This late-life immortality can be
explained in terms a late-life plateau in the force of natural selection. This
three-phase pattern of mortality leads to a new perspective on the extension of
life and the attainment of biological immortality.


Stephen Spindler

Chipping away at the mysteries of aging: What you don’t eat can’t hurt
you

The
fewer calories eaten (provided malnutrition is avoided) the slower animals age,
and the lower their death rate from cancer, heart disease, kidney disease, and
diabetes. For the past several years we have been using gene-chips to monitor
the expression of tens of thousands of genes at a time. Our results suggest
that shifting to a low calorie diet very rapidly begins to reverse deleterious
age-related changes in gene expression, and move animals to an apparently
younger profile. Gene-chip profiling has given us a practical way to initially
screen pharmaceuticals and nutrients for their ability to prevent the onset of
age-related diseases, and to actually slow aging itself.


Brian Wowk

Issues and Technologies for Long-Term Tissue Storage

Tissue
preservation has life extension applications ranging from stem cell storage to
organ transplantation, and ultimately suspended animation. Cryopreserved
tissues must be stored at temperatures low enough to stop chemical reactions,
but not so low that organs suffer thermal stress fractures. Successful cooling,
storage, and rewarming requires navigating a difficult course through problems
of chemistry, thermal stress, and ice crystal nucleation. Current knowledge of
this field will be reviewed, and technologies for storage of large masses at
temperatures other than liquid nitrogen will be discussed.

TUTORIAL
ABSTRACTS


Greg Fahy
and Brian Wowk
Extreme Life Prolongation at Cryogenic Temperatures

This
tutorial will review the basic principles of cryobiology and then explore what
is known about how long living systems can be kept in a state of low temperature
suspended animation under various conditions, with particular emphasis on the
safety of storage at temperatures above the temperature of liquid nitrogen.
Time will be set aside for questions and answers about any aspect of
cryobiology that may be of interest to the audience.


Aubrey de Grey

Cancer: why it is now the main barrier to extreme life extension, and a
revolutionary new approach to defeating it indefinitely

The
genomic instability that underlies cancer makes it enormously harder to combat
indefinitely than any other aspect of aging. Its only clear-cut "Achilles
heel" is the absolute need to stabilise telomeres (usually with
telomerase); if this can be prevented with total certainty by deleting (not
just suppressing) a vital gene, cancer will be prevented. However, many of our
normal cells need telomerase for their normal function. I will explain why
existing anti-cancer approaches are unlikely ever to postpone cancer by more
than a decade or two, and then present a radical, feasible solution, involving
the periodic re-seeding of our various stem cell pools with cells whose
telomeres have been re-lengthened ex vivo.


Ralph C. Merkle

Nanotechnology: how it will transform medicine and enable repair of
cryopreserved tissue

Nanotechnology
— the ability to easily and inexpensively arrange atoms and molecules in most
of the ways permitted by physical law — will revolutionize medicine. It will
let us build molecular medical tools able to directly address the fundamental
cellular and molecular causes of disease and ill health. Combining this new
ability to directly arrange and rearrange molecular structure with
immobilization of unhealthy tissue by cryopreservation will permit extended
analysis and repair. This approach avoids the rapid deterioration that can
limit the time available for medical procedures when damaged tissues are kept
at normal temperatures. Total repair of even extensively damaged tissue will,
for the first time, be feasible.


Jerry Lemler

and Alcor Staff
The New Alcor Cryonic Suspension Protocols

How
are cryonics services actually delivered today, and how will they be delivered
tomorrow? Dr. Jerry Lemler, Alcor’s President and CEO, along with personnel who
have participated in numerous cryonics cases, will explain improvements that
have been achieved in patient care; and legal, financial, medical, and political
obstacles that must be overcome in order to offer optimal cryopreservation with
minimal risk.

Speaker Biographies

Fifth Alcor
Conference
on Extreme Life Extension

Alcor: providing cryonic suspension
services since 1972



Speaker Biographies

 

Michael
D. West, Ph.D.


is the President, Chief Executive Officer and Chairman
of A.C.T. Group of Worcester, Massachusetts; a company focused on the medical
and agricultural applications of nuclear transfer (cloning) technologies.
He manages the Company’s subsidiaries: Advanced Cell Technology, Inc., Cyagra,
LLC, and CIMA Biotechnology, Inc.. He received his Ph.D. From Baylor College
of Medicine and has focused his academic and business career on the application
of developmental biology to the age-related degenerative disease. He was the
Founder of Geron Corporation of Menlo Park, California and from 1990 to 1998
he was the Director, and Vice President, where he initiated and managed programs
in telomerase diagnostics, telomerase inhibition, telomerase-mediated therapy,
and human Embryonic Stem (ES) cells.



Gregory
Benford, Ph.D.

is a working scientist who has written some 23 critically-acclaimed
novels. He has received two Nebula Awards, principally in 1981 for Timescape,
a novel which sold over a million copies. It also won the John W. Campbell
Memorial Award, the Australian Ditmar Award, and the British Science Fiction
Award. In 1992, Dr. Benford received the United Nations Medal in Literature.
He is also a professor of physics at the University of California, Irvine
since 1971. He specializes in astrophysics and plasma physics theory and was
presented with the Lord Prize in 1995 for achievements in the sciences. He
is a Woodrow Wilson Fellow and Phi Beta Kappa. Over the years, he has been
an advisor to the National Aeronautics and Space Administration, the United
Sates Department of Energy, and the White House Council on Space Policy, and
has served as a visiting fellow at Cambridge University. Currently he holds
research grants from NASA and the Jet Propulsion Laboratory. He is the author
of 140 research papers in his field, and has also published in biology and
climate change. His first book-length work of non-fiction, Deep Time (1999),
examines his work in long duration messages from a broad humanistic and scientific
perspective.

Ray
Kurzweil, Ph.D.

was the principal developer of the first omni-font optical
character recognition, the first print-to-speech reading machine for the blind,
the first CCD flat-bed scanner, the first text-to-speech synthesizer, the
first music synthesizer capable of recreating the grand piano and other orchestral
instruments, and the first commercially marketed large vocabulary speech recognition.
Ray has successfully founded, developed, and sold four AI businesses in OCR,
music synthesis, speech recognition, and reading technology. All of these
technologies continue today as market leaders.

Ray Kurzweil received the $500,000 Lemelson-MIT Prize,
the world’s largest award in invention and innovation. He also received the
1999 National Medal of Technology, the nation’s highest honor in technology,
from President Clinton in a White House ceremony. He has also received scores
of other national and international awards.


Kat
Cotter, D.C.

is Vice President of Maximum Life Foundation. Until
recently, she was the Director of Lifespan Longevity Center in Los Angeles,
California and partner in the Chiropractic and Wellness group. She left private
practice to dedicate herself full-time to work with the foundation and help
further life extension research. She is certified through the American Board
of Anti-Aging Medicine by the New York Chiropractic College as an Anti-Aging
practitioner. She holds a doctorate in Chiropractic through Southern California
University of Health Sciences along with certifications in several other areas.
She has experience in public relations, public speaking, marketing, and in
the planning and development of conferences and seminars. Dr. Cotter is President
and co-founder of the virtualhealthfair.com, a health resource site. She is
also the director of The Longevity Bootcamp, the first conference on aging
designed for the general public, which focuses on what can be done right now
to help people take charge of their own aging process. She is Co-Chair for
this year’s Extreme Life Extension Conference. She is a member of Alcor Life
Extension Foundation and is on their Board of Directors.

,
tutorial
Aubrey
de Grey, Ph.D.

received his BA, MA and PhD degrees from the University
of Cambridge, Cambridge, UK, where he is currently a research associate. His
main research areas are the role and etiology of oxidative damage in mammalian
aging, including both mitochondrial and extracellular free radical production
and damage, and the design of interventions to reverse the age-related accumulation
of oxidative and other damage.


,
tutorial
Gregory
Fahy, Ph.D.

received his bachelor of science degree from the University
of California at Irvine in 1972 and his Ph.D. in pharmacology from the Medical
College of Georgia in 1977. He then moved to the American Red Cross, where
he directed an organ cryopreservation program until leaving in 1994 to become
the Head of the Tissue Cryopreservation Section of the Transfusion and Cryopreservation
Research Program of the Naval Medical Research Institute in Bethesda, Maryland.
At the time he joined NMRI, he also became the Chief Scientist of two biotechnology
companies, LRT (currently Life Science Holdings) and Organ, Inc. (currently
Organ Recovery Systems). He left Maryland in 1997 and currently is the Chief
Scientific Officer and Vice President of 21st Century Medicine in Rancho Cucamonga,
California.



Robert
A. Freitas, Jr., J.D.

is a Research Scientist at Zyvex Corp. in Texas, a Research
Fellow at the Institute for Molecular Manufacturing in California, and author
of Nanomedicine, Vol. I (Landes Bioscience, 1999), the first technical book
on medical nanorobotics. In 1996, he authored the first detailed technical
design study of a medical nanorobot ever published in a peer-reviewed biomedical
journal, and has twice been a finalist for the annual Feynman Prize in Nanotechnology.
Freitas is presently completing Volumes II and III of Nanomedicine and is
consulting on molecular assembler design at Zyvex.


Steven
B. Harris, MD

was trained as an internist and geriatrician, and is now
Director of Research at Critical Care Research, Inc. He has been interested
in experimental gerontology and has published work in dietary restriction experiments
in mice, and in humans in Biosphere II. His current work is in experimental
induction of very rapid hypothermia in lab animals by means of liquid fluorocarbon
breathing. The goal of this work is to ultimately make possible brain resuscitation
without damage, after half an hour or more of cardiac arrest and “clinical death”.
Dr. Harris is a contributing editor of SKEPTIC magazine and a self-confessed
enthusiast of science fiction, usenet, and scuba.

Rudi
Hoffman CFP

is an independent Certified Financial Planner and investment
and insurance broker based in Daytona, FL. Mr. Hoffman is the leading writer
of life insurance in the world for the purpose of funding biostasis, with
over 100 policies written in the last few years alone. He is also an Alcor
member since 1994, and counts cryonicists among his best friends. “Ending
the stranglehold that death has on us all is the most important work we can
do for humanity. My passion to help show people how cryonics is affordable
grows from my personal experience and my hatred of death and aging.” Mr. Hoffman
has been in financial services since 1978.

David
A. Kekich

serves as chief Executive Officer and Chairman of Transvio Technology Ventures,
LLC. Mr. Kekich founded the country’s largest life insurance master general
agency, co-founded the world’s biggest private stock loan company and arranged
venture capital funding for private companies. He is a recognized expert on
private investing and authored the venture capital handbook “How The Rich
Get Richer With Quiet Private Investments”. Mr. Kekich founded both public
and private companies, was engaged as a consultant and served as director
to numerous private and public corporations. He has also sold and developed
real estate. In 1999, Mr. Kekich founded the “Maximum Life Foundation”, a
501(c)(3) corporation dedicated to controlling aging.

TutorialJerry
Lemler, MD

is a Board Certified psychiatrist who came to Alcor from
Tennessee in March of 2001 to become the organization’s first full-time Medical
Director. In September of the same year, Dr. Lemler was elected President
and CEO of Alcor by the Board of Directors. Dr. Lemler is a native of New
Rochelle, NY, who earned an undergraduate degree from the University of Tennessee
in Knoxville and a medical degree from the University of Tennessee College
of Medicine in Memphis. Following his formal psychiatric residency training
in Norristown, Pennsylvania, Dr. Lemler was in private psychiatric practice
in Mobile, Alabama, after which he served four years as the Chief of Staff
of Lakeshore Mental Health Institute in Knoxville, TN. In 1994 Dr. Lemler
received The National Exemplary Psychiatrist Award from The National Alliance
for the Mentally Ill.

tutorialRalph
C. Merkle, Ph.D.

received his Ph.D. from Stanford University in 1979 where
he co-invented public key cryptography. He joined Xerox PARC in 1988, where
he pursued research in computational nanotechnology until 1999. He is now
Vice President, Technology Assessment at Foresight and a Nanotechnology Theorist
at Zyvex, where he continues to pursue research in nanotechnology. He chaired
the Fourth and Fifth Foresight Conferences on Nanotechnology, was corecipient
of the 1998 Feynman Prize for Nanotechnology for theory, and was corecipient
of the ACM’s Kanellakis Award for Theory and Practice, the 2000 RSA Award
in Mathematics, and the IEEE Kobayashi Award. Dr. Merkle has published and
spoken extensively and has ten patents. His home page is at www.merkle.com.


Max More, Ph.D.

studied philosophy, economics, and politics at Oxford
University and the University of Southern California. As President of Extropy
Institute he synthesizes diverse perspectives and disciplines to look for
ways to use advanced technologies to improve the human condition. He is author
of “The Extropian Principles”, a document codifying the extropian transhumanist
movement’s shared goals of moving beyond human limits. He is also Director
of Content Solutions and Futures specialist at ManyWorlds, Inc. More frequently
lectures, writes, and appears in the media on issues surrounding the impact
of emerging technologies. Dr. More has organized several multi-disciplinary
conferences on advanced and emerging technologies and their effects on culture
and business and has spoken internationally at many conferences on future
trends. He has been a member of the Alcor Foundation since 1986.




Natasha Vita-More

is a media artist, lecturer and writer. She is founder
of Transhumanist Arts & Culture, an organization that encourages a well-rounded
and cross-disciplinary fusion of ideas in discussing and dealing with the
future. She is a long-time activist for new technologies, environmental problem
solving, advanced education, and the preservation of human dignity. She is
known for breaching gaps in public awareness of transhumanity and building
bridges for cultural sustenance of superlongevity. Her future body design
Primo Posthuman (3M+)" has received worldwide acclaim. Exhibitions:
London Contemporary Museum, Brooks Memorial Museum, Olympic Arts Festival,
Telluride Film Festival, Filmex International, American Film Festival, Kyoto
Convention Center, and Accademia Belle Arti.

Christine
Peterson

writes, lectures, and briefs the media on nanotechnology.
She is co-founder and President of Foresight Institute, a nonprofit which
educates the public, technical community, and policymakers on nanotechnology
and its long-term effects. She directs the Foresight
Conferences on Molecular Nanotechnology, organizes the Foresight
Institute Feynman Prizes, and chairs the Foresight
Gatherings. She lectures on nanotechnology to a wide variety of audiences,
focusing on making this complex field understandable. With Eric Drexler and
Gayle Pergamit, she wrote Unbounding
the Future: the Nanotechnology Revolution (Morrow, 1991), which sketches
nanotechnology’s potential environmental and medical benefits as well as possible
abuses.


Michael
R. Rose, Ph.D.

went to the University of Sussex in 1976 for his doctoral
studies on aging in Drosophila melanogaster. There he began his work on the
evolution of aging and created Drosophila stocks with postponed aging by selection
for later reproduction. In 1991, his Evolutionary Biology of Aging appeared,
offering a view of aging that was a complete departure from the views that
had dominated the aging field since 1960. Evolution described the field of
gerontology as having become “after Rose”. In 1997, Rose was awarded the Busse
Research Prize by the World Congress of Gerontology.

Stephen
Spindler, Ph.D.

is a Professor of Biochemistry at the University of California,
Riverside, and the Chief Scientific Officer at Biomarker Pharmaceuticals,
Inc. He earned his B.S. in Biology at the University of California, San Diego
in 1970 and his Ph.D. in Biomedical Sciences with a focus in Biochemistry
at the University of Texas Graduate School of Biomedical Sciences in Houston,
Texas in 1976. He performed Postdoctoral studies in the Department of Biochemistry
at Colorado State University and in the Endocrine Research Division of the
University of California, San Francisco. In 1981 he joined the faculty at
the University of California, Riverside. For the past 17 years, he has studied
the molecular biology of caloric restriction and aging.

,
tutorial Brian
Wowk, Ph.D.

is a physicist and senior scientist at 21st Century Medicine,
Inc. He earned his B.Sc. in physics, M.Sc. in medical physics, and Ph.D. in
physics in 1997 at the University of Manitoba. His graduate studies encompassed
radiotherapy physics and magnetic resonance imaging of human brain function.
He has numerous publications in the fields of medical imaging and cryobiology,
and holds four patents. His work in the field of nanotechnology has been featured
in Popular Mechanics magazine. Dr. Wowk is currently a staff scientist at
21st Century Medicine, Inc., where his work includes development of synthetic
ice blocking molecules, and engineering of organ perfusion systems.